218150 — Milae Bioresources Co Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeMicro CapNeutral

Annual income statement for Milae Bioresources Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	47,497	66,668	75,635	60,016	62,453
Cost of Revenue
Gross Profit	6,790	8,480	9,527	8,205	7,988
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	46,082	64,813	74,053	60,215	63,150
Operating Profit	1,415	1,855	1,582	-199	-697
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,034	1,144	905	393	-517
Provision for Income Taxes
Net Income After Taxes	953	1,079	878	359	-420
Minority Interest
Net Income Before Extraordinary Items
Net Income	955	1,015	963	441	-433
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	955	1,015	963	441	-433
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	53.7	57	50.8	33	6.94
Dividends per Share